Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.7K Buy
252
+20
+9% +$7.13K 0.04% 145
2025
Q4
$76.1K Hold
232
0.04% 154
2025
Q3
$65.6K Hold
232
0.03% 161
2025
Q2
$64.9K Buy
232
+1
+0.4% +$283 0.04% 160
2025
Q1
$71.8K Sell
231
-8
-3% -$2.36K 0.04% 154
2024
Q4
$62.2K Buy
239
+2
+0.8% +$593 0.03% 157
2024
Q3
$76.3K Buy
237
+2
+0.9% +$654 0.04% 143
2024
Q2
$73.5K Buy
235
+2
+0.9% +$588 0.04% 144
2024
Q1
$66.4K Buy
233
+1
+0.4% +$293 0.04% 148
2023
Q4
$66.7K Buy
232
+2
+0.9% +$545 0.04% 143
2023
Q3
$61.8K Buy
230
+2
+0.9% +$499 0.04% 141
2023
Q2
$50.6K Buy
228
+2
+0.9% +$464 0.04% 149
2023
Q1
$54.6K Buy
226
+2
+0.9% +$491 0.04% 145
2022
Q4
$58.7K Buy
+224
New +$60K 0.04% 138

Other funds holding AMGN

Financial Freedom LLC's AMGN Position: Q1 2026 in Review

Financial Freedom LLC increased its Amgen (AMGN) stake by 8.6% in Q1 2026, buying an estimated $7.13K and bringing the position to 252 shares worth $88.7K. The position accounts for 0.04% of the portfolio, ranked #145.

Financial Freedom LLC first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Financial Freedom LLC held 252 shares of Amgen worth $88.7K as of Q1 2026.
  • Financial Freedom LLC bought 20 Amgen shares in Q1 2026, an estimated $7.13K.
  • Amgen made up 0.04% of Financial Freedom LLC's portfolio in Q1 2026, its #145 holding.
  • Financial Freedom LLC first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Financial Freedom LLC's 13F filing for Q1 2026, filed 30 Apr 2026.